4.6 Article

Quantitative Determination of 5-Aminoisoquinoline, a PARP-1 Inhibitor by UPLC-MS/MS: In Silico ADME Profile and In Vitro Metabolic Stability Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Eco-Friendly, Simple, Fast, and Sensitive UPLC-MS/MS Method for Determination of Pexidartinib in Plasma and Its Application to Metabolic Stability

Essam Ezzeldin et al.

Summary: Pexidartinib is the first drug approved by the FDA to treat tenosynovial giant cell tumor. In this study, a validated UPLC-MS/MS assay was developed to quantify pexidartinib in plasma samples, and its metabolic stability in liver microsomes was estimated.

MOLECULES (2022)

Article Medicine, Research & Experimental

Poly(ADP-ribose) polymerase-1 inhibitor ameliorates dextran sulfate sodium-induced colitis in mice by regulating the balance of Th17/Treg cells and inhibiting the NF-κB signaling pathway

Shuai Peng et al.

Summary: The PARP-1 inhibitor 5-AIQ demonstrates significant pharmacological effects in a mouse model of colitis by reducing tissue damage and inflammation, modulating immune balance, and downregulating key components of signaling pathways.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Neurosciences

5-Aminoisoquinolinone, a PARP-1 Inhibitor, Ameliorates Immune Abnormalities through Upregulation of Anti-Inflammatory and Downregulation of Inflammatory Parameters in T Cells of BTBR Mouse Model of Autism

Khaled Alhosaini et al.

Summary: This study investigated the effects of 5-AIQ treatment on a mouse model of autism spectrum disorder (ASD), finding that it significantly increased certain cell populations while decreasing others, and modulated the expression levels of related genes and proteins in the brain. The results suggest that 5-AIQ may have promising therapeutic effects on neuroimmune dysfunction in ASD by modulating Treg and Th17 cells.

BRAIN SCIENCES (2021)

Review Cell Biology

The multifaceted roles of PARP1 in DNA repair and chromatin remodelling

Arnab Ray Chaudhuri et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)

Review Chemistry, Multidisciplinary

Analytical techniques in pharmaceutical analysis: A review

Masoom Raza Siddiqui et al.

ARABIAN JOURNAL OF CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly(ADP-Ribose)Polymerases (PARPs)

Michael D. Threadgill

CURRENT MEDICINAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice

Sheikh Fayaz Ahmad et al.

MOLECULAR IMMUNOLOGY (2015)

Review Biochemistry & Molecular Biology

Functional Aspects of PARP1 in DNA Repair and Transcription

Hui Ling Ko et al.

BIOMOLECULES (2012)

Article Urology & Nephrology

PARP-1 Inhibits Glycolysis in Ischemic Kidneys

Kishor Devalaraja-Narashimha et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Review Chemistry, Medicinal

Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists

Laxmikant A. Gharat et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2008)

Review Biotechnology & Applied Microbiology

Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

P Jagtap et al.

NATURE REVIEWS DRUG DISCOVERY (2005)

Article Pharmacology & Pharmacy

5-Aminoisoquinolinone reduces colon injury by experimental colitis

S Cuzzocrea et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)

Article Biochemistry & Molecular Biology

Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD+ depletion and cell death induced by oxidative stress

LN Du et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)